-
1
-
-
0034687430
-
Inflammatory markers of coronary risk
-
Rader D.J. Inflammatory markers of coronary risk. N. Engl. J. Med. 343 (2000) 1179-1182
-
(2000)
N. Engl. J. Med.
, vol.343
, pp. 1179-1182
-
-
Rader, D.J.1
-
2
-
-
0035023128
-
Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance
-
Kern P.A., Ranganathan S., Li C., et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol.: Endocrinol. Metab. 280 (2001) E745-E751
-
(2001)
Am. J. Physiol.: Endocrinol. Metab.
, vol.280
-
-
Kern, P.A.1
Ranganathan, S.2
Li, C.3
-
3
-
-
33747084116
-
Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects
-
Andreozzi F., Laratta E., Cardellini M., et al. Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects. Diabetes 55 (2006) 2021-2024
-
(2006)
Diabetes
, vol.55
, pp. 2021-2024
-
-
Andreozzi, F.1
Laratta, E.2
Cardellini, M.3
-
4
-
-
0035144307
-
Insulin/IGF-1 and TNF- stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways
-
Rui L., Aguirre V., Kim J.K., Shulman G.I., Lee A., Corbould A., Dunaif A., and White M.F. Insulin/IGF-1 and TNF- stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J. Clin. Invest. 107 (2001) 181-189
-
(2001)
J. Clin. Invest.
, vol.107
, pp. 181-189
-
-
Rui, L.1
Aguirre, V.2
Kim, J.K.3
Shulman, G.I.4
Lee, A.5
Corbould, A.6
Dunaif, A.7
White, M.F.8
-
5
-
-
0034230589
-
Antioxidants and vitamins to reduce cardiovascular disease
-
Devaraj S., and Jialal I. Antioxidants and vitamins to reduce cardiovascular disease. Curr. Atheroscler. Rep. 2 (2000) 342-351
-
(2000)
Curr. Atheroscler. Rep.
, vol.2
, pp. 342-351
-
-
Devaraj, S.1
Jialal, I.2
-
6
-
-
23944493587
-
Vitamin E, oxidative stress and inflammation
-
Singh U., Devraj S., and Jialal I. Vitamin E, oxidative stress and inflammation. Annu. Rev. Nutr. 25 (2005) 151-174
-
(2005)
Annu. Rev. Nutr.
, vol.25
, pp. 151-174
-
-
Singh, U.1
Devraj, S.2
Jialal, I.3
-
7
-
-
0025949842
-
Cytokines in sera from insulin-dependent diabetic patients at diagnosis
-
Cavallo M.G., Pozzilli P., Bird C., Wadhwa M., Meager A., Visalli N., Gearing A.J., Andreani D., and Thorpe R. Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin. Exp. Immunol. 86 (1991) 256-259
-
(1991)
Clin. Exp. Immunol.
, vol.86
, pp. 256-259
-
-
Cavallo, M.G.1
Pozzilli, P.2
Bird, C.3
Wadhwa, M.4
Meager, A.5
Visalli, N.6
Gearing, A.J.7
Andreani, D.8
Thorpe, R.9
-
8
-
-
0842264588
-
Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes
-
Jain S.K., Kannan K., Lim G., Matthew-Greer J., McVie R., and Bocchini J.A. Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes. Diabetes Care 26 (2003) 2139-2143
-
(2003)
Diabetes Care
, vol.26
, pp. 2139-2143
-
-
Jain, S.K.1
Kannan, K.2
Lim, G.3
Matthew-Greer, J.4
McVie, R.5
Bocchini, J.A.6
-
9
-
-
0030030135
-
Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM
-
Hussain M.F., Peakman M., Gallati H., Lo S.S.S., Hawa M., Viberti G.C., Watkins P.J., Leslie R.D.G., and Vergani D. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 39 (1996) 60-69
-
(1996)
Diabetologia
, vol.39
, pp. 60-69
-
-
Hussain, M.F.1
Peakman, M.2
Gallati, H.3
Lo, S.S.S.4
Hawa, M.5
Viberti, G.C.6
Watkins, P.J.7
Leslie, R.D.G.8
Vergani, D.9
-
10
-
-
0036305669
-
Hyperketonemia increases TNF-α secretion in cultured U937 monocytes and type-1 diabetic patients
-
Jain S.K., Kannan K., Lim G., McVie R., and Bocchini J.A. Hyperketonemia increases TNF-α secretion in cultured U937 monocytes and type-1 diabetic patients. Diabetes 51 (2002) 2287-2293
-
(2002)
Diabetes
, vol.51
, pp. 2287-2293
-
-
Jain, S.K.1
Kannan, K.2
Lim, G.3
McVie, R.4
Bocchini, J.A.5
-
11
-
-
0035034309
-
Effects of tumor necrosis factor-a on insulin action in cultured human muscle cells
-
Halse R., Pearson S.L., McCormack J.G., Yeaman S.J., and Taylor R. Effects of tumor necrosis factor-a on insulin action in cultured human muscle cells. Diabetes 50 (2001) 1102-1109
-
(2001)
Diabetes
, vol.50
, pp. 1102-1109
-
-
Halse, R.1
Pearson, S.L.2
McCormack, J.G.3
Yeaman, S.J.4
Taylor, R.5
-
12
-
-
0030028606
-
The expression of TNF-a by human muscle. Relationship to insulin resistance
-
Saghizadesh M., Ong J.M., Garvey W.T., Henry R.R., and Kern P.A. The expression of TNF-a by human muscle. Relationship to insulin resistance. J. Clin. Invest. 97 (1996) 1111-1116
-
(1996)
J. Clin. Invest.
, vol.97
, pp. 1111-1116
-
-
Saghizadesh, M.1
Ong, J.M.2
Garvey, W.T.3
Henry, R.R.4
Kern, P.A.5
-
13
-
-
0033024516
-
Mechanisms of chromium action: low-molecular weight chromium-binding substance
-
Vincent J.B. Mechanisms of chromium action: low-molecular weight chromium-binding substance. J. Am. Coll. Nutr. 18 (1999) 6-12
-
(1999)
J. Am. Coll. Nutr.
, vol.18
, pp. 6-12
-
-
Vincent, J.B.1
-
14
-
-
7444270286
-
Role of chromium in human health and in diabetes
-
Cefalu W.T., and Hu F.B. Role of chromium in human health and in diabetes. Diabetes Care 27 (2004) 2741-2751
-
(2004)
Diabetes Care
, vol.27
, pp. 2741-2751
-
-
Cefalu, W.T.1
Hu, F.B.2
-
15
-
-
0030695031
-
Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes
-
Anderson R.A., Cheng N., Bryden N.A., Polansky M.M., Cheng N., Chi J., and Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46 (1997) 1786-1791
-
(1997)
Diabetes
, vol.46
, pp. 1786-1791
-
-
Anderson, R.A.1
Cheng, N.2
Bryden, N.A.3
Polansky, M.M.4
Cheng, N.5
Chi, J.6
Feng, J.7
-
16
-
-
0036303773
-
The safety and efficacy of high-dose chromium
-
Lamson D.M., and Plaza S.M. The safety and efficacy of high-dose chromium. Altern. Med. Rev. 7 (2002) 218-235
-
(2002)
Altern. Med. Rev.
, vol.7
, pp. 218-235
-
-
Lamson, D.M.1
Plaza, S.M.2
-
17
-
-
0027949040
-
Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM
-
Lee N.A., and Reasner C.A. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 17 (1994) 1449-1452
-
(1994)
Diabetes Care
, vol.17
, pp. 1449-1452
-
-
Lee, N.A.1
Reasner, C.A.2
-
18
-
-
0019272131
-
Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects
-
Offenbacher E.G., and Pi-Sunyer F.X. Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes 29 (1980) 919-925
-
(1980)
Diabetes
, vol.29
, pp. 919-925
-
-
Offenbacher, E.G.1
Pi-Sunyer, F.X.2
-
19
-
-
0020562853
-
Effects of chromium III on fasting blood glucose, cholesterol and cholesterol HDL levels in diabetics
-
Mossop R.T. Effects of chromium III on fasting blood glucose, cholesterol and cholesterol HDL levels in diabetics. Cent. Afr. J. Med. 29 (1983) 80-82
-
(1983)
Cent. Afr. J. Med.
, vol.29
, pp. 80-82
-
-
Mossop, R.T.1
-
20
-
-
0032946588
-
Follow-up survey of people in china with type 2 diabetes mellitus consuming supplemental chromium
-
Cheng N., Zhu X., Shi H., Wu W., Chi J., Cheng J., and Anderson R.A. Follow-up survey of people in china with type 2 diabetes mellitus consuming supplemental chromium. J. Trace Elem. Exp. Med. 12 (1999) 55-60
-
(1999)
J. Trace Elem. Exp. Med.
, vol.12
, pp. 55-60
-
-
Cheng, N.1
Zhu, X.2
Shi, H.3
Wu, W.4
Chi, J.5
Cheng, J.6
Anderson, R.A.7
-
21
-
-
0025775868
-
Chromium and cholesterol-induced atherosclerosis in rabbits
-
Abraham A.S., Brooks B.A., and Eylath U. Chromium and cholesterol-induced atherosclerosis in rabbits. Ann. Nutr. Metab. 35 (1991) 203-207
-
(1991)
Ann. Nutr. Metab.
, vol.35
, pp. 203-207
-
-
Abraham, A.S.1
Brooks, B.A.2
Eylath, U.3
-
22
-
-
0017355448
-
Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition
-
Jeejeebhoy K.N., Chu R.C., Marliss E.B., Greenberg G.R., and Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition. Am. J. Clin. Nutr. 30 (1977) 531-538
-
(1977)
Am. J. Clin. Nutr.
, vol.30
, pp. 531-538
-
-
Jeejeebhoy, K.N.1
Chu, R.C.2
Marliss, E.B.3
Greenberg, G.R.4
Bruce-Robertson, A.5
-
23
-
-
33646037640
-
Hypoglycemic potency of novel trivalent chromium in hyperglycemic insulin-deficient rats
-
Machalinski B., Walczak M., Syrenicz A., Machalinska A., Grymula K., Stecewicz I., Wiszniewska B., and Dabkowska E. Hypoglycemic potency of novel trivalent chromium in hyperglycemic insulin-deficient rats. J. Trace Elem. Med. Biol. 20 (2006) 33-39
-
(2006)
J. Trace Elem. Med. Biol.
, vol.20
, pp. 33-39
-
-
Machalinski, B.1
Walczak, M.2
Syrenicz, A.3
Machalinska, A.4
Grymula, K.5
Stecewicz, I.6
Wiszniewska, B.7
Dabkowska, E.8
-
24
-
-
33645464301
-
Inhibition of diabetic nephrophathy in rats by an oral antidiabetic material extracted from yeast
-
Nakhoul F., Abassi Z., Morgan M., Sussan S., and Mirsky N. Inhibition of diabetic nephrophathy in rats by an oral antidiabetic material extracted from yeast. J. Am. Soc. Nephrol. 17 (2006) S127-S131
-
(2006)
J. Am. Soc. Nephrol.
, vol.17
-
-
Nakhoul, F.1
Abassi, Z.2
Morgan, M.3
Sussan, S.4
Mirsky, N.5
-
25
-
-
17644365750
-
Oral administration of the biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats
-
Clodfelder B.J., Gullick B.M., Lukaski H.C., Neggers Y., and Vincent J.B. Oral administration of the biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats. Biol. Inorg. Chem. 10 (2005) 119-130
-
(2005)
Biol. Inorg. Chem.
, vol.10
, pp. 119-130
-
-
Clodfelder, B.J.1
Gullick, B.M.2
Lukaski, H.C.3
Neggers, Y.4
Vincent, J.B.5
-
26
-
-
4644247272
-
Insulin sensitizing action of chromium picolinate in various experimental models of diabetes mellitus
-
Shinde U.A., Sharma G., Xu Y.J., Dhalla N.S., and Goyal R.K. Insulin sensitizing action of chromium picolinate in various experimental models of diabetes mellitus. J. Trace Elem. Med. Biol. 18 (2004) 23-32
-
(2004)
J. Trace Elem. Med. Biol.
, vol.18
, pp. 23-32
-
-
Shinde, U.A.1
Sharma, G.2
Xu, Y.J.3
Dhalla, N.S.4
Goyal, R.K.5
-
27
-
-
2542505331
-
Anti-diabetic activity and mechanism of action of chromium chloride
-
Shinde U.A., Sharma G., Xu Y.J., Dhalla N.S., and Goyal R.K. Anti-diabetic activity and mechanism of action of chromium chloride. Exp. Clin. Endocrinol. Diabetes 112 (2004) 248-252
-
(2004)
Exp. Clin. Endocrinol. Diabetes
, vol.112
, pp. 248-252
-
-
Shinde, U.A.1
Sharma, G.2
Xu, Y.J.3
Dhalla, N.S.4
Goyal, R.K.5
-
28
-
-
1942534587
-
Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats
-
Kim D.S., Kim T.W., and Kang J.S. Chromium picolinate supplementation improves insulin sensitivity in Goto-Kakizaki diabetic rats. J. Trace Elem. Med. Biol. 17 (2004) 243-247
-
(2004)
J. Trace Elem. Med. Biol.
, vol.17
, pp. 243-247
-
-
Kim, D.S.1
Kim, T.W.2
Kang, J.S.3
-
29
-
-
0035983152
-
Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats
-
Cefalu W.T., Wang Z.Q., Zhang X.H., Baldor L.C., and Russell J.C. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J. Nutr. 132 (2002) 1107-1114
-
(2002)
J. Nutr.
, vol.132
, pp. 1107-1114
-
-
Cefalu, W.T.1
Wang, Z.Q.2
Zhang, X.H.3
Baldor, L.C.4
Russell, J.C.5
-
30
-
-
0026639242
-
Effect of chromium administration on glucose tolerance in stroke-prone spontaneously hypertensive rats with streptozotocin-induced diabetes
-
Yoshimoto S., Sakamoto K., Wakabayashi I., and Masui H. Effect of chromium administration on glucose tolerance in stroke-prone spontaneously hypertensive rats with streptozotocin-induced diabetes. Metabolism 41 (1992) 636-642
-
(1992)
Metabolism
, vol.41
, pp. 636-642
-
-
Yoshimoto, S.1
Sakamoto, K.2
Wakabayashi, I.3
Masui, H.4
-
31
-
-
33646870326
-
Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus
-
Racek J., Trefil L., Rajdl D., Mudrova V., Hunter D., and Senft V. Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus. Biol. Trace Elem. Res. 109 (2006) 215-230
-
(2006)
Biol. Trace Elem. Res.
, vol.109
, pp. 215-230
-
-
Racek, J.1
Trefil, L.2
Rajdl, D.3
Mudrova, V.4
Hunter, D.5
Senft, V.6
-
32
-
-
22444436664
-
Supplementation with chromium picolinate recovers renal Cr concentration and improves carbohydrate metabolism and renal function in type 2 diabetic mice
-
Mita Y., Ishihara K., Fukuchi Y., Fukuva Y., and Yasumoto K. Supplementation with chromium picolinate recovers renal Cr concentration and improves carbohydrate metabolism and renal function in type 2 diabetic mice. Biol. Trace Elem. Res. 105 (2005) 229-248
-
(2005)
Biol. Trace Elem. Res.
, vol.105
, pp. 229-248
-
-
Mita, Y.1
Ishihara, K.2
Fukuchi, Y.3
Fukuva, Y.4
Yasumoto, K.5
-
33
-
-
0036853770
-
Beneficial effects of a novel IH636 grape seed proanthocyanidin extract and a niacin-bound chromium in a hamster atherosclerosis model
-
Vinson J.A., Mandarano M.A., Shuta D.L., Bagchi M., and Bachi D. Beneficial effects of a novel IH636 grape seed proanthocyanidin extract and a niacin-bound chromium in a hamster atherosclerosis model. Mol. Cell. Biochem. 240 (2002) 99-103
-
(2002)
Mol. Cell. Biochem.
, vol.240
, pp. 99-103
-
-
Vinson, J.A.1
Mandarano, M.A.2
Shuta, D.L.3
Bagchi, M.4
Bachi, D.5
-
34
-
-
34248144819
-
Transcriptome of the subcutaneous adipose tissue in response to oral supplementation of type 2 Leprdb obese diabetic mice with niacin-bound chromium
-
Rink C., Roy S., Khanna S., Rink T., Bagchi D., and Sen C.K. Transcriptome of the subcutaneous adipose tissue in response to oral supplementation of type 2 Leprdb obese diabetic mice with niacin-bound chromium. Physiol. Genomics 27 (2007) 279-370
-
(2007)
Physiol. Genomics
, vol.27
, pp. 279-370
-
-
Rink, C.1
Roy, S.2
Khanna, S.3
Rink, T.4
Bagchi, D.5
Sen, C.K.6
-
35
-
-
33746601010
-
Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes
-
Martin J., Wang Z.Q., Zhang X.H., Wachtel D., Volaufova J., Matthews D.E., and Cefalu W.T. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 29 (2006) 1826-1832
-
(2006)
Diabetes Care
, vol.29
, pp. 1826-1832
-
-
Martin, J.1
Wang, Z.Q.2
Zhang, X.H.3
Wachtel, D.4
Volaufova, J.5
Matthews, D.E.6
Cefalu, W.T.7
-
36
-
-
17044363062
-
Chromium supplementation shortenes QTc interval duration in patients with type 2 diabetes mellitus
-
Vrtovic M., Vertovec B., Briski A., Kocijancic A., Anderson R.A., and Radovancevic B. Chromium supplementation shortenes QTc interval duration in patients with type 2 diabetes mellitus. Am. Heart J. 149 (2005) 632-636
-
(2005)
Am. Heart J.
, vol.149
, pp. 632-636
-
-
Vrtovic, M.1
Vertovec, B.2
Briski, A.3
Kocijancic, A.4
Anderson, R.A.5
Radovancevic, B.6
-
38
-
-
32444441358
-
Chromium picolinate enhances skeletal muscle cellular insulin siganaling in vivo in obese, insulin-resistant JCR:LA-cp Rats
-
Wang Z.Q., Zhang X.H., Russel J.C., Hulver M., and Cefalu W.T. Chromium picolinate enhances skeletal muscle cellular insulin siganaling in vivo in obese, insulin-resistant JCR:LA-cp Rats. J. Nutr. 136 (2006) 415-420
-
(2006)
J. Nutr.
, vol.136
, pp. 415-420
-
-
Wang, Z.Q.1
Zhang, X.H.2
Russel, J.C.3
Hulver, M.4
Cefalu, W.T.5
-
39
-
-
33645381037
-
Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism
-
Chen G., Liu P., Pattar G.R., Tackett L., Bhonagiri P., Strawbridge A.B., and Elmendorf J.S. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol. Endocrinol. 20 (2006) 857-870
-
(2006)
Mol. Endocrinol.
, vol.20
, pp. 857-870
-
-
Chen, G.1
Liu, P.2
Pattar, G.R.3
Tackett, L.4
Bhonagiri, P.5
Strawbridge, A.B.6
Elmendorf, J.S.7
-
40
-
-
33749234572
-
Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions
-
Pattar G.R., Tackett L., Liu P., and Elmendorf J.S. Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions. Mutat. Res. 610 (2006) 93-100
-
(2006)
Mutat. Res.
, vol.610
, pp. 93-100
-
-
Pattar, G.R.1
Tackett, L.2
Liu, P.3
Elmendorf, J.S.4
-
41
-
-
0035824432
-
Chromium chloride inhibits oxidative stress and TNF-α secretion caused by exposure to high glucose in cultured monocytes
-
Jain S.K., and Kannan K. Chromium chloride inhibits oxidative stress and TNF-α secretion caused by exposure to high glucose in cultured monocytes. Biochem. Biophys. Res. Commun. 289 (2001) 687-691
-
(2001)
Biochem. Biophys. Res. Commun.
, vol.289
, pp. 687-691
-
-
Jain, S.K.1
Kannan, K.2
-
42
-
-
33645709588
-
Chromium chloride inhibits TNF-α and IL-6 secretion in isolated human blood monoclear cells exposed to high glucose
-
Jain S.K., and Lim G. Chromium chloride inhibits TNF-α and IL-6 secretion in isolated human blood monoclear cells exposed to high glucose. Horm. Metab. Res. 38 (2006) 60-62
-
(2006)
Horm. Metab. Res.
, vol.38
, pp. 60-62
-
-
Jain, S.K.1
Lim, G.2
-
43
-
-
0024408737
-
Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes
-
Jain S.K., McVie R., Duett J., and Herbst J.J. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38 (1989) 1539-1543
-
(1989)
Diabetes
, vol.38
, pp. 1539-1543
-
-
Jain, S.K.1
McVie, R.2
Duett, J.3
Herbst, J.J.4
-
44
-
-
0021288842
-
Detection of malonaldehyde by high-performance liquid chromatography
-
Esterbauer H., Lang J., Zadravec S., and Slater T. Detection of malonaldehyde by high-performance liquid chromatography. Methods Enzymol. 105 (1984) 319-328
-
(1984)
Methods Enzymol.
, vol.105
, pp. 319-328
-
-
Esterbauer, H.1
Lang, J.2
Zadravec, S.3
Slater, T.4
-
45
-
-
23444455019
-
Teonail chromium and risk of myocardial infarction
-
Guallar E.J.F., van't Veer P., Bode P., Riemersma R., Gomez-Aracena J., Kark J., Arab L., Kok F., and Martin-Moreno J.M. Teonail chromium and risk of myocardial infarction. Am. J. Epidemiol. 162 (2005) 157-164
-
(2005)
Am. J. Epidemiol.
, vol.162
, pp. 157-164
-
-
Guallar, E.J.F.1
van't Veer, P.2
Bode, P.3
Riemersma, R.4
Gomez-Aracena, J.5
Kark, J.6
Arab, L.7
Kok, F.8
Martin-Moreno, J.M.9
-
46
-
-
4444300965
-
Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men
-
Rajpathak S., Rimm E.B., Li T., Morris J.S., Stampfer M.J., Willett W.C., and Hu F.B. Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care 27 (2004) 2211-2216
-
(2004)
Diabetes Care
, vol.27
, pp. 2211-2216
-
-
Rajpathak, S.1
Rimm, E.B.2
Li, T.3
Morris, J.S.4
Stampfer, M.J.5
Willett, W.C.6
Hu, F.B.7
-
47
-
-
33644647009
-
Trivalent chromium inhibits protein glycation and lipid peroxidation in high glucose treated erythrocytes
-
Jain S.K., Patel P., Rogier K., and Jain S.K. Trivalent chromium inhibits protein glycation and lipid peroxidation in high glucose treated erythrocytes. Antioxid. Redox Signal. 8 (2006) 238-241
-
(2006)
Antioxid. Redox Signal.
, vol.8
, pp. 238-241
-
-
Jain, S.K.1
Patel, P.2
Rogier, K.3
Jain, S.K.4
-
49
-
-
0035444539
-
Signal transduction by tumor necrosis factor and its relatives
-
Baud V., and Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11 (2001) 372-377
-
(2001)
Trends Cell Biol.
, vol.11
, pp. 372-377
-
-
Baud, V.1
Karin, M.2
-
50
-
-
0032943709
-
C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?
-
Yudkin J.S., Stehouwer C.D., Emeis J.J., et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 972-978
-
(1999)
Arterioscler. Thromb. Vasc. Biol.
, vol.19
, pp. 972-978
-
-
Yudkin, J.S.1
Stehouwer, C.D.2
Emeis, J.J.3
-
51
-
-
0035125965
-
Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-alpha in 3T3-L1 adipocytes
-
Rosenstock M., Greenberg A.S., and Rudich A. Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-alpha in 3T3-L1 adipocytes. Diabetologia 44 (2001) 55-62
-
(2001)
Diabetologia
, vol.44
, pp. 55-62
-
-
Rosenstock, M.1
Greenberg, A.S.2
Rudich, A.3
-
52
-
-
3042677716
-
C-reactive protein: risk marker or mediator in atherothrombosis
-
Jialal I., Devraj S., and Venugopal S.K. C-reactive protein: risk marker or mediator in atherothrombosis. Hypertension 44 (2004) 6-11
-
(2004)
Hypertension
, vol.44
, pp. 6-11
-
-
Jialal, I.1
Devraj, S.2
Venugopal, S.K.3
-
53
-
-
0031892271
-
TNF-alpha and insulin resistance: summary and future prospects
-
Peraldi P., and Spiegelman B. TNF-alpha and insulin resistance: summary and future prospects. Mol. Cell. Biochem. 182 (1998) 169-175
-
(1998)
Mol. Cell. Biochem.
, vol.182
, pp. 169-175
-
-
Peraldi, P.1
Spiegelman, B.2
-
54
-
-
18244370762
-
Inflammation, stress, and oxidative stress
-
Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and oxidative stress. J. Clin. Invest. 115 (2005) 1111-1119
-
(2005)
J. Clin. Invest.
, vol.115
, pp. 1111-1119
-
-
Wellen, K.E.1
Hotamisligil, G.S.2
-
55
-
-
22644437126
-
Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review
-
Carlson L.A. Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review. J. Intern. Med. 258 (2005) 97-114
-
(2005)
J. Intern. Med.
, vol.258
, pp. 97-114
-
-
Carlson, L.A.1
-
56
-
-
20144383819
-
The effect of nicotinic acid and alcohol co-administration in Wistar rats
-
Kolovou G.D., Mikhalidis D.P., Adamopoulou E.N., Salpea K.D., Kafaltis N., Bilianou H.G., Malakos J., Pilatis N.D., Mykoniatis M., and Cokkinos D.V. The effect of nicotinic acid and alcohol co-administration in Wistar rats. Methods Find. Exp. Clin. Pharmacol. 27 (2005) 17-23
-
(2005)
Methods Find. Exp. Clin. Pharmacol.
, vol.27
, pp. 17-23
-
-
Kolovou, G.D.1
Mikhalidis, D.P.2
Adamopoulou, E.N.3
Salpea, K.D.4
Kafaltis, N.5
Bilianou, H.G.6
Malakos, J.7
Pilatis, N.D.8
Mykoniatis, M.9
Cokkinos, D.V.10
-
57
-
-
8644267972
-
Hyperglycemia-induced oxidative stress in diabetic complications
-
King G.L., and Loeken M.R. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem. Cell Biol. 122 (2004) 333-338
-
(2004)
Histochem. Cell Biol.
, vol.122
, pp. 333-338
-
-
King, G.L.1
Loeken, M.R.2
-
58
-
-
30344486998
-
Oxidative stress and diabetic cardiovascular complications
-
Jay D., Hitomi H., and Griendling K.K. Oxidative stress and diabetic cardiovascular complications. Free Radic. Biol. Med. 40 (2006) 183-192
-
(2006)
Free Radic. Biol. Med.
, vol.40
, pp. 183-192
-
-
Jay, D.1
Hitomi, H.2
Griendling, K.K.3
-
59
-
-
0032401572
-
Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells
-
Jain S.K., Kannan K., and Lim G. Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Radic. Biol. Med. 25 (1998) 1083-1088
-
(1998)
Free Radic. Biol. Med.
, vol.25
, pp. 1083-1088
-
-
Jain, S.K.1
Kannan, K.2
Lim, G.3
-
60
-
-
0032832864
-
Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients
-
Jain S.K., and McVie R. Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients. Diabetes 48 (1999) 555-1850
-
(1999)
Diabetes
, vol.48
, pp. 555-1850
-
-
Jain, S.K.1
McVie, R.2
-
61
-
-
0024803840
-
Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells
-
Jain S.K. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J. Biol. Chem. 264 (1989) 21340-21345
-
(1989)
J. Biol. Chem.
, vol.264
, pp. 21340-21345
-
-
Jain, S.K.1
-
62
-
-
0034625372
-
Molecular mechanisms of tumor necrosis factor a gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways
-
Guha M., Bai W., Nadler J.L., and Natarajan R. Molecular mechanisms of tumor necrosis factor a gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J. Biol. Chem. 275 (2000) 17728-17739
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 17728-17739
-
-
Guha, M.1
Bai, W.2
Nadler, J.L.3
Natarajan, R.4
-
63
-
-
0033037930
-
Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells
-
Yerneni K.K., Bai W., Khan B.V., Medford R.M., and Natarajan R. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes 48 (1999) 855-864
-
(1999)
Diabetes
, vol.48
, pp. 855-864
-
-
Yerneni, K.K.1
Bai, W.2
Khan, B.V.3
Medford, R.M.4
Natarajan, R.5
-
64
-
-
0033051632
-
Effect of hyperketonemia on lipid peroxidation levels of plasma in diabetic patients
-
Jain S.K., McVie R., Jackson R., Levine S.N., and Lim G. Effect of hyperketonemia on lipid peroxidation levels of plasma in diabetic patients. Diabetes Care 22 (1999) 171-1175
-
(1999)
Diabetes Care
, vol.22
, pp. 171-1175
-
-
Jain, S.K.1
McVie, R.2
Jackson, R.3
Levine, S.N.4
Lim, G.5
-
65
-
-
20044376702
-
The pathogenesis of diabetic complications: a unifying mechanism
-
Brownlee M. The pathogenesis of diabetic complications: a unifying mechanism. Diabetes 54 (2005) 1615-1625
-
(2005)
Diabetes
, vol.54
, pp. 1615-1625
-
-
Brownlee, M.1
-
66
-
-
34548488370
-
Oxidative stress and the JNK pathway in diabetes
-
Kaneto H., Matsuoka T., Nakatani Y., Kawamori D., Matsuhisa M., and Yamasaki Y. Oxidative stress and the JNK pathway in diabetes. Curr. Diabetes Rev. 1 (2005) 65-72
-
(2005)
Curr. Diabetes Rev.
, vol.1
, pp. 65-72
-
-
Kaneto, H.1
Matsuoka, T.2
Nakatani, Y.3
Kawamori, D.4
Matsuhisa, M.5
Yamasaki, Y.6
-
67
-
-
27944443627
-
Enhanced oxidative stress and endothelial dysfunction in streptozotocin-diabetic rats exposed to fine particles
-
Lei Y.-C., Hwang J.-S., Chan C.-C., Lee C.-T., and Cheng T.-J. Enhanced oxidative stress and endothelial dysfunction in streptozotocin-diabetic rats exposed to fine particles. Environ. Res. 99 (2005) 335-343
-
(2005)
Environ. Res.
, vol.99
, pp. 335-343
-
-
Lei, Y.-C.1
Hwang, J.-S.2
Chan, C.-C.3
Lee, C.-T.4
Cheng, T.-J.5
-
68
-
-
33748082985
-
Differentialexpression of proteins in kidney, eye, aorta, and serum of diabetic and non-diabetic rats
-
Cho W.C., Yip T.-T., Chung W.-S., Leung A.W., Cheng C.H., and Yue K.K. Differentialexpression of proteins in kidney, eye, aorta, and serum of diabetic and non-diabetic rats. J. Cell. Biochem. 99 (2006) 256-268
-
(2006)
J. Cell. Biochem.
, vol.99
, pp. 256-268
-
-
Cho, W.C.1
Yip, T.-T.2
Chung, W.-S.3
Leung, A.W.4
Cheng, C.H.5
Yue, K.K.6
|